Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma

Cancer

Volumn 79, Issue 8, 1997, Pages 1600-1604

  Neugut, Alfred I ^a,b,d   Ahsan, Habibul ^b   Robinson, Eliezer ^c   Ennis, Ronald D ^a  

^a The New York Presbyterian Hospital   (United States)

^b New York State Psychiatric Institute   (United States)

^c RAMBAM MEDICAL CENTER   (Israel)

^d New York State Psychiat Inst and New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

bladder carcinoma; prostate carcinoma; radiation; radiation therapy; second malignant neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SECOND CANCER;

AGED; COHORT STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; LEUKEMIA, RADIATION-INDUCED; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROSTATIC NEOPLASMS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 0030909335     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970415)79:8<1600::AID-CNCR24>3.0.CO;2-0     Document Type: Article

References (23)

1. Boice JD Jr., Storm HH, Curtis RE, Jenson OM, Kleinermann RA, Jenson HS, et al. Multiple primary cancers in Connecticut and Denmark. Natl Cancer Inst Monogr 1985; 68.
2. Committee on the Biological Effects of Ionizing Radiation, National Research Council. Health effects of exposure to low levels of ionizing radiation (BEIR V). Washington, DC: National Academy Press, 1990.
3. Neugut AI, Murray T, Santos J, Amols H, Hayes MK, Flannery JT, et al. Increased risk of lung cancer following breast cancer radiation therapy in cigarette smokers. Cancer 1994; 73:1615-20.
4. Kleinerman RA, Boice JD Jr., Storm HH, Sparen P, Andersen A, Pukkala E, et al. Second primary cancer after treatment for cervical cancer. Cancer 1995;76:442-52.
5. Boice JD Jr., Day NE, Andersen A, Brinton LA, Brown R, Choi NW, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. 7 Natl Cancer Inst 1985;74:955-75.
6. Kaldor JM, Day NE, Kittelmann B, Pettersson F, Langmark F, Pedersen D, et al. Bladder tumors following chemotherapy and radiotherapy for ovarian cancer: a case-control study. Int J Cancer 1995;63:1-6.
7. Wingo PA, Tong C, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
8. Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, et al. Prostate Cancer Clinical Guidelines Panel summary report on the management of clinically localized prostate cancer. J Urol 1995; 154:2144-8.
9. Blasko JC, Grimm PD, Radge H. Brachytherapy and organ preservation in the management of carcinoma of the prostate. Semin Radiat Oncol 1993;3:240-9.
10. Mettlin CJ, Murphy GP, McGinnis LS, Menck HR. National Cancer Data Base report on prostate cancer. Cancer 1995;76:1104-12.
11. Miller BA, Ries LAG, Hankey BF, Kosary CL, Harras A, Devesa SS, et al. SEER Cancer Statistics Review: 1973-1990. NIH Publication #93-2729. Bethesda (MD) : National Cancer Institute, 1993 NIH Pub. No. 93-278.
12. Surveillance, Epidemiology, and End Results (SEER) Pro-gram. Special public use tape (1973-90). Bethesda (MD): National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch, 1993.
13. Breslow NE, Day NE. Statistical methods of cancer research. Volume 2. The design and analysis of cohort studies. IARC Scientific Publ. #82. Lyon, France: IARC, 1987.
14. Robinson E, Neugut AI, Wylie P. Clinical aspects of post-irradiation sarcomas. J Natl Cancer Inst 1988;80:233-40.
15. Greenberg RS, Rustin ED, Clark WS. Risk of genitourinary malignancies after cancer of the prostate. Cancer 1988; 61:396-401.
16. Liskow AS, Neugut AI, Benson M, Olsson CA, Birkhoff J, Chang CH. Multiple primary neoplasms in association with prostate cancer in black and white patients. Cancer 1987; 59:380-4.
17. Kleinerman RA, Liebermann JV, Li FP. Second cancer following cancer of the male genital system in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:139-47.
18. Pilepich MV, Asbell SO, Krall JM, Baerwald W, Sause WT, Rubin P, et al. Correlation of radiotherapeutic parameters and treatment related morbidity: analysis of RTOG study 77-06. Int J Radiat Oncol Biol Phys 1987;13:1007-12.
19. Oosterlinck W, Kurth K, Schroder F, Bultinck J, Hammond B, Sylvester R. A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta-T1 papillary carcinoma of the bladder. J Urol 1993;149:749-52.
20. Prout GR, Barton J, Friedell PPGGH. History of non-invasive grade I transitional cell carcinoma. J Urol 1992;148:1413-9.
21. Perez CA. Carcinoma of the prostate. In: Ferez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia: J.B. Lippincott, 1987:877-9.
22. Asbell SO, Krall JM, Pilepich MD, Baerwald H, Sause WT, Hanks GE, et al. Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06. Int J Radiat Oncol Biol Phys 1988;15:1307-16.
23. Peschel RE. External beam radiation therapy for local prostate cancer. In: Ernstoff M, Heaney G, Peschel RE, editors. Urologic cancer. Cambridge: Blackwell Science, 1996:117-36.